| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |